Restamax Plc: DECISIONS OF RESTAMAX PLC'S ANNUAL GENERAL

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
66
Restamax Plc: DECISIONS OF RESTAMAX PLC'S ANNUAL GENERAL MEETING

Restamax Plc STOCK EXCHANGE RELEASE 26 APRIL 2017 at 17.00 DECISIONS OF RESTAMAX PLC'S ANNUAL GENERAL MEETINGRestamax Plc's Annual General Meeting was held today 26 April 2017 in Tampere. The meeting confirmed the 2016 financial statements and discharged the Company's management from liability. The meeting decided that, based on the balance sheet confirmed for the financial period that ended on 31 December 2016, a dividend of EUR 0.30 per share will be paid. The dividend will be paid on 10 May 2017. The Annual General Meeting decided that the Board of Directors will comprise six (6) members and elected Deloitte & Touche Oy as the Company's auditor. The meeting was opened by Chairman of the Board Timo Laine, lawyer Heli Piksilä-Rantanen chaired the meeting, and lawyer Hannu Selin acted as Secretary. DECISIONS OF THE GENERAL MEETINGFinancial statementsThe meeting adopted Restamax Plc's financial statements and discharged the members of the Board of Directors and the CEO from liability for the 2016 financial period. DividendThe Board of Directors decided that, based on the balance sheet adopted for the financial period that ended on 31 December 2016, a dividend of EUR 0.30 per share will be paid. The dividend record date is 28 April 2017, and the dividend payment date is 10 May 2017. Board of DirectorsThe meeting decided that the number of members of the Board of Directors will be six (6). As members of the Board, the meeting re-elected all present members of the Board, Timo Laine, Petri Olkinuora, Mikko Aartio, Jarmo Viitala, Mika Niemi and Timo Everi, to serve until the end of the next Annual General Meeting. The meeting elected Timo Laine as Chairman of the Board and Petri Olkinuora as Vice-Chairman. The Annual General Meeting decided that the payment of remuneration and travel expense reimbursements to the members of the Board of Directors would be as follows until the following Annual General Meeting: annual remuneration to the Chairman of the Board will be EUR 25,000, to the Vice-Chairman EUR 20,000 and to other members EUR 10,000. Separate attendance allowances are not paid. Travel expenses will be reimbursed in accordance with the Company's travel rules. AuditorThe Annual General Meeting reselected as auditor Deloitte & Touche Oy, a firm of authorised public accountants, until the end of the next Annual General Meeting. Hannu Mattila, APA, will act as the Company's responsible auditor. In accordance with the Board's proposal, the meeting decided that the auditor's remuneration will be paid based on a reasonable invoice approved by the Company. Authorisation to purchase the Company's own sharesThe Annual General Meeting decided to authorise the Board to decide on using the Company's unrestricted equity to purchase no more than 800,000 of the Company's own shares in one or several tranches, taking into account the stipulations of the Limited Liability Companies Act regarding the maximum number of shares in possession of the Company and under the following terms: The Company's own shares shall be purchased with the funds from the Company's unrestricted equity, decreasing the distributable profits of the Company. The shares shall be purchased in trading on the regulated market in the Helsinki Stock Exchange, and therefore the purchase takes place by private placing and not in relation to the shares owned by the shareholders. The sum paid for the shares is the price announced on the acquisition day for Restamax Plc's shares on the regulated market on the stock list of Helsinki Stock Exchange. The shares are purchased in trading organised by Nasdaq Helsinki Oy in accordance with its rules and regulations. The shares can be purchased for financing or carrying out possible corporate acquisitions or other arrangements, to implement incentive schemes within the Company, or for other purposes decided by the Board. The maximum amount of the shares to be purchased is equivalent to approximately 4.8 per cent of all the shares and votes of the Company calculated using the share count on the publication date of the invitation to the Annual General Meeting, so the purchase of the shares does not have a significant influence on the share ownership and the distribution of voting rights in the Company. The Board of Directors shall decide on other matters related to the purchase of the Company's own shares. The authorisation will expire at the end of the 2018 Annual General Meeting, however no later than 18 months of the Annual General Meeting's authorisation decision. Authorisation to decide on share issueThe meeting decided, as proposed by the Board of Directors, to authorise the Board of Directors to decide on a share issue under the following terms: With this authorisation, the Board may decide to issue a maximum of 1,500,000 new shares, and to transfer no more than 800,000 of the Company's own shares held by the Company ("Share Issue Authorisation"). The new shares can be issued and the Company's own shares held by it can be assigned in one or more instalments, either with or without payment. The new shares can be issued and the Company's own shares held by it can be assigned to Company shareholders in proportion to the Company shares that they already own or, deviating from the shareholders' pre-emptive right, in a special share issue if, from the Company's perspective, there is a justified financial reason for it, such as the financing or implementation of corporate acquisitions or other arrangements, development of the Company's equity structure, improvement of share liquidity or the implementation of Company incentives schemes. The issue of new shares or transfer of the Company's own shares held by the Company can also take place against apport property or by using a claim for the Company held by the subscriber to redeem the amount to be paid for the issue price or the price to be paid for the shares. A special issue may only be arranged without payment if a justified financial reason exists in terms of the overall benefit of the Company and all of its shareholders. The Board of Directors was authorised to decide on other matters related to share issues. The Share Issue Authorisation will expire at the end of the Annual General Meeting of 2018, however no later than 18 months from  the Annual General Meeting's Share Issue Authorisation decision. Minutes of the Annual General MeetingThe minutes of the Annual General Meeting are available to shareholders at the Restamax Plc head office and on the Company's website at www.restamax.fi/en/investors/general-meeting/annual-general-meeting-2017 on 10 May 2017 or sooner. Additional information:Chairman of the Board of Directors Timo Laine, Restamax Plc, tel. +358 400 626 064 CEO Markku Virtanen, Restamax Plc, tel. +358 400 836 477 Distribution:NASDAQ OMX Helsinki Major media www.restamax.fiRestamax Plc is a Finnish restaurant business and labour hire services group established in 1996. The company, which listed on NASDAQ OMX Helsinki in 2013 and became the first Finnish listed restaurant company, has continued to grow strongly throughout its history. The Group companies include some 120 restaurants, nightclubs and entertainment centres all over Finland. Well-known restaurant concepts of the Group include Stefan's Steakhouse, Viihdemaailma Ilona, Classic American Diner and Colorado Bar & Grill. In 2016, Restamax Plc's turnover was MEUR 130.1 and EBITDA MEUR 19.4. Depending on the season, some 1,100 persons converted into full-time employees work at the Group. The workforce of Restamax subsidiary Smile Henkilöstöpalvelut Oy is about 4,500.Restamax company website: www.restamax.fi, Restamax consumer website: www.ravintola.fi, Smile Henkilöstöpalvelut: www.smilepalvelut.fi

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IM Cannabis's Third Quarter Financial Jolt

Updated Category News Views 120

IM Cannabis Takes a Hit, But Seeks New Angles Diving into IM Cannabis's (NASDAQ: IMCC) latest financial splash is like reading a weathered old map of the stock market. The third quarter of 2026 wasn't kind to this little cannabis outfit. Revenues have nosedived to C$1.65 million from last year's C$5.08 million. It's not just the typical bad quarter blues; it's a solid...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 102

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Enjay Acquires New Method: A Strategic Synergy Unfolds

Updated Category News Views 98

Enjay's Bold Move into New Territory Here's a headline that doesn’t just flutter past like yesterday's news. Enjay Converters Ltd, straight from Cobourg, Ontario, has clinched a deal that looks like it might just shake things up a bit on the food packaging scene. They’ve bagged New Method Packaging LLC, another big player, but this time from the heartland of...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 104

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
Hybrid Bonding Market Shooting to $2.45 Billion by 2033

Updated Category News Views 126

Hybrid Bonding: The Future of Semiconductor Interconnects? Mark these words: Hybrid bonding isn't just another tech trend—it’s morphing into a billion-dollar juggernaut, my friend. With the latest numbers from MarketsandMarkets™, we see a potential leap from USD 0.38 billion in 2026 to a staggering USD 2.45 billion by 2033. We'll be seeing an eye-popping CAGR of...

Continue Reading
Sino Bio Speeds AI Drug Discovery with 4RISE Launch

Updated Category News Views 80

AI Meets Real-World Validation In the world of cutting-edge biotech, Sino Biological is turning heads with its latest move. If you're in the game of AI-driven drug discovery, their new 4RISE™ high-throughput wet-lab validation services could be the breakthrough you've been waiting for. Why? Well, the promise of AI is dazzling, but it all boils down to how fast you can...

Continue Reading
NVIDIA Faces Legal Turbulence: CEO's Exit Sparks Chaos

Updated Category News Views 161

Jensen Huang's Sudden Exit: A Barrage of Headlines In what feels like a blow delivered by a sledgehammer, NVIDIA is rocked by the abrupt resignation of its iconic co-founder and CEO, Jensen Huang. This isn't some quiet departure into the night. Nope, it's more like a cannonball being fired into the investor lounge, leaving a wreckage for all to navigate through. Huang's...

Continue Reading
Nonprofit and Partners Gift Homes to Veterans

Updated Category News Views 87

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

Continue Reading
BETR Investors Face Action: Nov. 20 Deadline Nears

Updated Category News Views 121

High Stakes for BETR Shareholders If you're holding shares in Better Home & Finance Holding Company, right now might feel like you're at a craps table with emptying pockets. BETR, trading under NASDAQ, has become the center of a legal hurricane, with investors eyeing the November 20th deadline to join a securities class action led by Hagens Berman. The class period in...

Continue Reading
Philip Scroggie's Legacy in Global Energy Projects

Updated Category News Views 116

A Lifetime of Energy Industry Excellence When you've been around the block in the energy sector as long as Philip D. Scroggie has, you're bound to pick up a few accolades. Recognized as an Inner Circle Lifetime Member, this guy has etched his name in the annals of global energy project management. Yeah, he's been a heavyweight in the oil, gas, and LNG industries, and he's...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting New Indoor Adventure: Albatross to Open Soon

Updated Category News Views 418

Albatross: A New Era in Indoor Entertainment Get ready for an unparalleled experience as Albatross prepares to open its doors, offering a unique blend of indoor mini putting, luxury bowling, craft cocktails, and vibrant dining options. This venue promises to redefine leisure and entertainment as we know it. Grand Opening Celebration Mark your calendars for the grand...

Continue Reading
Navigating Innovation: Key Insights from CIOs Worldwide

Updated Category News Views 179

Understanding the Evolving Role of CIOs The 2025 CIO Report, released by Logicalis, offers invaluable insights gathered from the perspectives of over 1,000 CIOs across the globe. The report highlights a significant shift in the responsibilities of CIOs, revealing that 95% of organizations are making technological investments focused on generating new revenue streams...

Continue Reading
Jake Owen Set to Light Up NASCAR All-Star Race Weekend Concert

Updated Category News Views 447

Exciting Concert Announcement for NASCAR All-Star Race Weekend As part of the thrilling NASCAR All-Star Race weekend, the multi-talented Jake Owen will take the stage on Saturday night as a centerpiece of the festivities. Presented by Raymer Oil, this special performance is eagerly anticipated by both race aficionados and country music fans alike. The event will be held...

Continue Reading
Keros Therapeutics Secures FDA Orphan Drug Designation for KER-065

Updated Category News Views 166

Keros Therapeutics Secures FDA Orphan Drug Designation Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company based in Lexington, has made significant strides in the treatment landscape for Duchenne muscular dystrophy (DMD) by announcing that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation for its promising candidate, KER-065....

Continue Reading
AM Best Upholds Credit Ratings for Partners Life Limited

Updated Category News Views 186

AM Best Today Affirms Partners Life Limited's Credit Ratings Recently, AM Best provided a significant update, affirming the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a” (Excellent) for Partners Life Limited. These ratings reflect a stable outlook for the company, underscoring its strong financial positioning in the insurance...

Continue Reading